DIFFERENT EFFECTS OF SEQUENTIAL COMBINATIONS OF N-METHYLFORMAMIDE WITH 5-FLUOROURACIL ON HUMAN COLON-CARCINOMA CELLS GROWING IN NUDE-MICE

被引:15
作者
ARANCIA, G
LEONETTI, C
MALORNI, W
GRECO, C
FORMISANO, G
MARANGOLO, M
ZUPI, G
机构
[1] REGINA ELENA INST CANC RES,EXPTL CHEMOTHERAPY,ROME,ITALY
[2] CITY HOSP RAVENNA,MED ONCOL UNIT,RAVENNA,ITALY
关键词
N-METHYLFORMAMIDE; 5-FLUOROURACIL; DRUG COMBINATION; PRECLINICAL PHARMACOLOGY; HUMAN COLON CARCINOMA; NUDE MICE;
D O I
10.1007/BF01630719
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effects of the combination of N-methylformamide (NMF) with 5-fluorouracil (5-FU) on tumor growth and morphological features of human colon carcinoma cells (HT29) implanted in nude mice were assessed. Both agents were administered i.p. at tolerable doses: 5-FU at 19 mg/kg for 5 days and NMF at 200 mg/kg for 12 days. Four main schedules were tested: 5-FU alone, NMF alone, NMF followed by 5-FU and 5-FU followed by NMF. The last sequence was the most effective, as compared with the other treatment regimens. In particular, the 5-FU --> NMF combination induced a tumor inhibition of about 75% at the end of the treatments (17th day) versus an inhibition of 23%-43% in the other schedules. Morphological observations, carried out by light and electron microscopy, indicated a possible relationship between the presence of structural changes and tumor growth inhibition. The results of this study renew interest in the use of NMF in sequential combination confirming sequence as a critical factor for the optimal combination of NMF and 5-FU.
引用
收藏
页码:351 / 358
页数:8
相关论文
共 37 条
[1]  
BARCLAY RK, 1957, CANCER RES, V17, P345
[2]   CLINICAL AND PHARMACOLOGICAL IMPLICATIONS OF CANCER CELL-DIFFERENTIATION AND HETEROGENEITY [J].
CALABRESI, P ;
DEXTER, DL ;
HEPPNER, GH .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (12) :1933-1941
[3]  
CHATTERJEE D, 1986, P AM ASSOC CANC RES, V27, P9
[4]  
CHRISTENSEN TG, 1985, CANCER-AM CANCER SOC, V56, P1559, DOI 10.1002/1097-0142(19851001)56:7<1559::AID-CNCR2820560716>3.0.CO
[5]  
2-T
[6]   N-METHYLFORMAMIDE - CYTO-TOXIC, RADIOSENSITIZER, OR CHEMOSENSITIZER [J].
CLAGETTCARR, K ;
SAROSY, G ;
PLOWMAN, J ;
HOTH, DF ;
LEYLANDJONES, B .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :906-918
[7]   TERMINAL DIFFERENTIATION OF HUMAN PROMYELOCYTIC LEUKEMIA-CELLS INDUCED BY DIMETHYL-SULFOXIDE AND OTHER POLAR COMPOUNDS [J].
COLLINS, SJ ;
RUSCETTI, FW ;
GALLAGHER, RE ;
GALLO, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (05) :2458-2462
[8]   REVERSAL BY L-CYSTEINE OF THE GROWTH INHIBITORY AND GLUTATHIONE-DEPLETING EFFECTS OF N-METHYLFORMAMIDE AND N,N-DIMETHYLFORMAMIDE [J].
CORDEIRO, RF ;
SAVARESE, TM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 122 (02) :798-803
[9]  
CORDEIRO RF, 1986, CANCER RES, V46, P1297
[10]  
DEXTER DL, 1977, CANCER RES, V37, P3136